Shell Companies
Compare Stocks
5 / 10Stock Comparison
DAIC vs ACMR vs ICHR vs IDAI vs AMAT
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Software - Application
Semiconductors
DAIC vs ACMR vs ICHR vs IDAI vs AMAT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Semiconductors | Semiconductors | Software - Application | Semiconductors |
| Market Cap | $21M | $3.92B | $2.47B | $3M | $325.54B |
| Revenue (TTM) | $173K | $901M | $959M | $4M | $28.37B |
| Net Income (TTM) | $-39M | $94M | $-51M | $-12M | $7.00B |
| Gross Margin | -99.2% | 44.4% | 11.3% | 60.0% | 48.7% |
| Operating Margin | -40.8% | 12.1% | -3.8% | -183.3% | 29.2% |
| Forward P/E | — | 29.7x | 62.2x | — | 37.1x |
| Total Debt | $600K | $303M | $186M | $4M | $6.55B |
| Cash & Equiv. | $433K | $766M | $98M | $3M | $7.24B |
DAIC vs ACMR vs ICHR vs IDAI vs AMAT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| CID HoldCo, Inc. Co… (DAIC) | 100 | 3.8 | -96.2% |
| ACM Research, Inc. (ACMR) | 100 | 228.6 | +128.6% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 362.7 | +262.7% |
| T Stamp Inc. (IDAI) | 100 | 97.3 | -2.7% |
| Applied Materials, … (AMAT) | 100 | 224.2 | +124.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DAIC vs ACMR vs ICHR vs IDAI vs AMAT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DAIC ranks third and is worth considering specifically for stability.
- Beta 1.34 vs ICHR's 3.93
ACMR is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- 30.7% 10Y total return vs AMAT's 20.1%
- Lower volatility, beta 3.24, Low D/E 15.7%, current ratio 3.27x
- PEG 0.84 vs AMAT's 2.16
ICHR is the clearest fit if your priority is momentum.
- +329.1% vs DAIC's -99.5%
Among these 5 stocks, IDAI doesn't own a clear edge in any measured category.
AMAT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 8 yrs, beta 2.14, yield 0.4%
- Beta 2.14, yield 0.4%, current ratio 2.61x
- 24.7% margin vs DAIC's -11.8%
- 0.4% yield, 8-year raise streak, vs ACMR's 0.2%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs DAIC's -60.7% | |
| Value | Lower P/E (29.7x vs 37.1x), PEG 0.84 vs 2.16 | |
| Quality / Margins | 24.7% margin vs DAIC's -11.8% | |
| Stability / Safety | Beta 1.34 vs ICHR's 3.93 | |
| Dividends | 0.4% yield, 8-year raise streak, vs ACMR's 0.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +329.1% vs DAIC's -99.5% | |
| Efficiency (ROA) | 19.3% ROA vs DAIC's -5.2% |
DAIC vs ACMR vs ICHR vs IDAI vs AMAT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
DAIC vs ACMR vs ICHR vs IDAI vs AMAT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMAT leads in 3 of 6 categories
ACMR leads 2 • DAIC leads 0 • ICHR leads 0 • IDAI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMAT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMAT is the larger business by revenue, generating $28.4B annually — 164298.8x DAIC's $172,661. AMAT is the more profitable business, keeping 24.7% of every revenue dollar as net income compared to DAIC's -11.8%. On growth, IDAI holds the edge at +70.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $172,661 | $901M | $959M | $4M | $28.4B |
| EBITDAEarnings before interest/tax | -$11M | $126M | -$11M | -$6M | $8.4B |
| Net IncomeAfter-tax profit | -$39M | $94M | -$51M | -$12M | $7.0B |
| Free Cash FlowCash after capex | -$5M | -$69M | -$17M | -$8M | $5.7B |
| Gross MarginGross profit ÷ Revenue | -99.2% | +44.4% | +11.3% | +60.0% | +48.7% |
| Operating MarginEBIT ÷ Revenue | -40.8% | +12.1% | -3.8% | -183.3% | +29.2% |
| Net MarginNet income ÷ Revenue | -11.8% | +10.4% | -5.3% | -3.2% | +24.7% |
| FCF MarginFCF ÷ Revenue | -19.1% | -7.6% | -1.7% | -2.2% | +20.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +9.4% | +4.7% | +70.7% | -3.5% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -76.1% | +46.2% | +32.1% | +13.9% |
Valuation Metrics
ACMR leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 43.2x trailing earnings, ACMR trades at a 9% valuation discount to AMAT's 47.4x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs AMAT's 2.76x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $21M | $3.9B | $2.5B | $3M | $325.5B |
| Enterprise ValueMkt cap + debt − cash | $21M | $3.5B | $2.6B | $4M | $324.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.98x | 43.21x | -46.25x | -0.22x | 47.40x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.68x | 62.25x | — | 37.07x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.22x | — | — | 2.76x |
| EV / EBITDAEnterprise value multiple | — | 27.49x | — | — | 38.68x |
| Price / SalesMarket cap ÷ Revenue | 122.27x | 4.35x | 2.61x | 0.89x | 11.48x |
| Price / BookPrice ÷ Book value/share | — | 2.06x | 3.67x | 0.86x | 16.25x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | 57.13x |
Profitability & Efficiency
AMAT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
AMAT delivers a 34.3% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $-190 for IDAI. ACMR carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to IDAI's 1.30x. On the Piotroski fundamental quality scale (0–9), AMAT scores 7/9 vs IDAI's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +6.1% | -7.5% | -189.5% | +34.3% |
| ROA (TTM)Return on assets | -5.2% | +3.9% | -5.2% | -105.4% | +19.3% |
| ROICReturn on invested capital | — | +7.0% | -3.9% | -2.2% | +33.3% |
| ROCEReturn on capital employed | -6.0% | +6.6% | -4.7% | -194.9% | +30.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 | 3 | 1 | 7 |
| Debt / EquityFinancial leverage | — | 0.16x | 0.28x | 1.30x | 0.32x |
| Net DebtTotal debt minus cash | $167,467 | -$463M | $87M | $1M | -$686M |
| Cash & Equiv.Liquid assets | $432,533 | $766M | $98M | $3M | $7.2B |
| Total DebtShort + long-term debt | $600,000 | $303M | $186M | $4M | $6.6B |
| Interest CoverageEBIT ÷ Interest expense | -38.09x | 20.44x | -5.97x | -22.08x | 35.46x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMAT five years ago would be worth $31,383 today (with dividends reinvested), compared to $53 for DAIC. Over the past 12 months, ICHR leads with a +329.1% total return vs DAIC's -99.5%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs DAIC's -82.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -62.1% | +31.9% | +249.0% | -38.4% | +52.9% |
| 1-Year ReturnPast 12 months | -99.5% | +195.6% | +329.1% | +20.9% | +164.7% |
| 3-Year ReturnCumulative with dividends | -99.5% | +487.9% | +151.1% | -87.5% | +258.7% |
| 5-Year ReturnCumulative with dividends | -99.5% | +133.4% | +28.9% | -99.1% | +213.8% |
| 10-Year ReturnCumulative with dividends | -99.5% | +3065.8% | +629.1% | +102.4% | +2014.4% |
| CAGR (3Y)Annualised 3-year return | -82.5% | +80.5% | +35.9% | -50.0% | +53.1% |
Risk & Volatility
Evenly matched — DAIC and ICHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
DAIC is the less volatile stock with a 1.34 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs DAIC's 0.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.34x | 3.24x | 3.93x | 1.99x | 2.14x |
| 52-Week HighHighest price in past year | $75.00 | $71.65 | $72.87 | $5.28 | $432.81 |
| 52-Week LowLowest price in past year | $0.16 | $19.26 | $13.12 | $1.80 | $151.51 |
| % of 52W HighCurrent price vs 52-week peak | +0.3% | +82.6% | +97.7% | +47.2% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 45.8 | 60.7 | 66.9 | 49.1 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 555K | 1.2M | 795K | 43K | 6.0M |
Analyst Outlook
AMAT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ACMR as "Buy", ICHR as "Buy", AMAT as "Buy". Consensus price targets imply 3.9% upside for AMAT (target: $426) vs -32.4% for ACMR (target: $40). For income investors, AMAT offers the higher dividend yield at 0.42% vs ACMR's 0.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | $40.00 | $49.80 | — | $426.39 |
| # AnalystsCovering analysts | — | 10 | 14 | — | 53 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | — | — | +0.4% |
| Dividend StreakConsecutive years of raises | — | 3 | 1 | — | 8 |
| Dividend / ShareAnnual DPS | — | $0.11 | — | — | $1.71 |
| Buyback YieldShare repurchases ÷ mkt cap | +75.6% | +0.2% | 0.0% | +2.1% | +1.5% |
AMAT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACMR leads in 2 (Valuation Metrics, Total Returns). 1 tied.
DAIC vs ACMR vs ICHR vs IDAI vs AMAT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DAIC or ACMR or ICHR or IDAI or AMAT a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -60. 7% for CID HoldCo, Inc. Common Stock (DAIC). ACM Research, Inc. (ACMR) offers the better valuation at 43. 2x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DAIC or ACMR or ICHR or IDAI or AMAT?
On trailing P/E, ACM Research, Inc.
(ACMR) is the cheapest at 43. 2x versus Applied Materials, Inc. at 47. 4x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus Applied Materials, Inc. 's 2. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DAIC or ACMR or ICHR or IDAI or AMAT?
Over the past 5 years, Applied Materials, Inc.
(AMAT) delivered a total return of +213. 8%, compared to -99. 5% for CID HoldCo, Inc. Common Stock (DAIC). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus DAIC's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DAIC or ACMR or ICHR or IDAI or AMAT?
By beta (market sensitivity over 5 years), CID HoldCo, Inc.
Common Stock (DAIC) is the lower-risk stock at 1. 34β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 193% more volatile than DAIC relative to the S&P 500. On balance sheet safety, ACM Research, Inc. (ACMR) carries a lower debt/equity ratio of 16% versus 130% for T Stamp Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DAIC or ACMR or ICHR or IDAI or AMAT?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -60. 7% for CID HoldCo, Inc. Common Stock (DAIC). On earnings-per-share growth, the picture is similar: T Stamp Inc. grew EPS 29. 3% year-over-year, compared to -156. 1% for CID HoldCo, Inc. Common Stock. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DAIC or ACMR or ICHR or IDAI or AMAT?
Applied Materials, Inc.
(AMAT) is the more profitable company, earning 24. 7% net margin versus -1179. 2% for CID HoldCo, Inc. Common Stock — meaning it keeps 24. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMAT leads at 29. 2% versus -40. 8% for DAIC. At the gross margin level — before operating expenses — IDAI leads at 65. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DAIC or ACMR or ICHR or IDAI or AMAT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus Applied Materials, Inc. 's 2. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACM Research, Inc. (ACMR) trades at 29. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 32. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMAT: 3. 9% to $426. 39.
08Which pays a better dividend — DAIC or ACMR or ICHR or IDAI or AMAT?
In this comparison, AMAT (0.
4% yield), ACMR (0. 2% yield) pay a dividend. DAIC, ICHR, IDAI do not pay a meaningful dividend and should not be held primarily for income.
09Is DAIC or ACMR or ICHR or IDAI or AMAT better for a retirement portfolio?
For long-horizon retirement investors, CID HoldCo, Inc.
Common Stock (DAIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DAIC: -99. 5%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DAIC and ACMR and ICHR and IDAI and AMAT?
These companies operate in different sectors (DAIC (Financial Services) and ACMR (Technology) and ICHR (Technology) and IDAI (Technology) and AMAT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DAIC is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock; IDAI is a small-cap quality compounder stock; AMAT is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.